After posting lower financial results for 2016, reinsurance firm
Swiss Re announced that it is undertaking reforms in its research activities with the help of pharmaceutical company Novartis.
According to its latest financials, Swiss Re’s net income dropped 20% to $3.6 billion last year.
Learn more about pharmaceutical insurance here.
The Financial Times reports that chief executive Christian Mumenthaler is trying to reinvent the company into a “risk knowledge” firm to leverage in-house expertise from modelling natural catastrophes and other hazards in recent years.
Want the latest insurance industry news first? Sign up for our completely free newsletter service now.
The reinsurer’s CEO also said that a new “Swiss Re Institute” will initiate research in behavioural economics and the digitalization of insurance.
Related stories:
Insurer shrinks headcount by 10,000
Swiss Re sees net income slump by $1 billion
